AKT1 and colon adenocarcinoma: Our study may pave the way to understanding that overexpression of LINC02257 in colon adenocarcinoma patients may alter PI3K-Akt signaling pathway, with its cascade involved in extracellular structure organization and ossification, providing potential targets for further investigation.